RT Book, Section
A1 Mattei, Peter L.
A1 Jones, Elizabeth K.
A1 Tsao, Hensin
A2 Avram, Marc R.
A2 Avram, Mathew M.
A2 Ratner, Désirée
SR Print(0)
ID 1175094470
T1 Surgical Management of Melanoma
T2 Procedural Dermatology
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 9780071795067
LK dermatology.mhmedical.com/content.aspx?aid=1175094470
RD 2024/04/23
AB In  the  past  several  decades,  the  incidence  of  melanoma  has  steadily  risen.  In  the  United  States,  as  of  2012,  it  is  estimated  that  76,250  new  cases  of  melanoma  will  develop  and  9,180  patients  will  die  of  the  disease.1  Data  from  2006  to  2008  projects  that  1  in  36  males  and  1  in  55  females  will  develop  invasive  melanoma  during  their  lifetime.1  The  median  age  of  diagnosis  is  59  years.  Furthermore,  the  projected  increase  in  the  incidence  of  melanoma  may  be  underestimated  due  to  unreported  outpatient  treatments  of  superficial  and  in  situ  melanomas.  Melanoma  is  one  of  the  leading  cancers  in  terms  of  average  years  of  life  lost  per  death  from  disease.2  Melanoma  has  higher  incidence  rates  in  lightly  pigmented  Caucasians  than  in  Hispanics,  Asians,  and  African  Americans.2  Estimates  indicate  that  82%  to  85%  of  patients  present  with  localized  disease,  10%  to  13%  with  regional  disease,  and  2%  to  5%  with  distant  metastatic  disease.3  Melanoma  is  responsible  for  the  majority  of  skin  cancer-related  deaths  but  is  often  cured  when  detected  early.  Outcome  depends  on  the  stage  at  presentation.